- Abstract:
-
OBJECTIVE: While the lipidosterolic extract (LSESr) of Serenoa repens--Permixon--has been shown to have an equivalent efficacy to finasteride in patients with benign prostatic hyperplasia (BPH), to date, there has been no valid comparison of phytotherapy with alpha-blockers. The aim of this study was to assess the equivalent efficacy of Permixon and tamsulosin. METHODS: Eight hundred and eleven men with symptomatic BPH (international prostdate symptom score, I-PSS > or = 10) were recruite...
Expand abstract - Publication status:
- Published
- Journal:
- Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
- Volume:
- 12
- Issue:
- 3
- Pages:
- 384-392
- Publication date:
- 2002-06-05
- ISSN:
-
1166-7087
- URN:
-
uuid:c5440ad5-88a6-47e6-83fd-7323ac176a0a
- Source identifiers:
-
120709
- Local pid:
- pubs:120709
- Language:
- French
- Keywords:
- Copyright date:
- 2002
Journal article
[Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record